Today’s top gainers include the company Quest Diagnostics Inc. (NYSE:DGX) which is in the industry Medical Laboratories & Research, gaining -0.23% today. In the last week its performance is -2.27%, and 8.00% for the past quarter. Currently, Quest Diagnostics Inc., DGX has a target price of 82.5, so today’s gain of -0.23% is a significant step towards its target price. The GAP today is therefore 0.31%.
Quest Diagnostics Inc. (NYSE:DGX), has a market cap of 11561.6, and is based in USA. Insider ownership is at 0.40%, and institutional ownership is 96.60%.
At the current price of 82.98, it has a dividend yield of 1.93%, and its target price is 82.5. This is with a profit margin of 11.00%, and total debt/equity of 0.85. Quest Diagnostics Inc. (NYSE:DGX) has a P/E of 14.52, as well as a forward P/E of 15.23.
With a current EPS of 5.72, and a forecasted EPS growth for next year at 6.68%,Quest Diagnostics Inc. (NYSE:DGX) has had a EPS growth for the past five years at 4.10%. For the next five years EPS growth is projected to be 7.82%.
Performance for the year is 22.82%. Since its IPO date on 12/26/1996, the total performance to date is 18.53%.
Volume today for Quest Diagnostics Inc. (NYSE:DGX), is 1614613, while its average volume is 1189.56. Whilst the total gain today was -0.23%, it did have a day high of -4.46%.
Volatility for this week has been at 1.31%, and 1.09% for the month. The 52-week low for Quest Diagnostics Inc., DGX has been 41.24%, while the 52-week-high has reached -4.46%.
Looking at its return of investments, which is 12.30%, and its return on assets is 8.20%. Quest Diagnostics Inc. (NYSE:DGX) has an operating margin of 20.70%. With a sales growth of -1.00% quarter over quarter. Bearing in mind that Quest Diagnostics Inc., DGX is in the sector Healthcare, its long-term debt/equity is 0.85, and has a current ratio of 1.4 and 1.3 for quick ratio.
So what is the value of Quest Diagnostics Inc.? Well its PEG is 1.86, and the P/S is 1.54, along with a P/B of 2.56. Meanwhile it has a p/cash of 40.85.